122 related articles for article (PubMed ID: 9252646)
21. [LDH activity in human ovarian tissue and in ovarian carcinoma (author's transl)].
Hofmann KD; Wagner F; Dziambor H; Preibsch W
Zentralbl Gynakol; 1982; 104(8):463-6. PubMed ID: 7113514
[TBL] [Abstract][Full Text] [Related]
22. Effects of long-term administration of UFT plus leucovorin on colorectal tumors induced with 1,2-dimethylhydrazine in rats.
Kuwa K; Sakamoto S; Sassa S; Yoshimura S; Maemura M; Nakayama T
Anticancer Res; 1999; 19(6B):5139-42. PubMed ID: 10697523
[TBL] [Abstract][Full Text] [Related]
23. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
Ishii T; Marumo K
Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5-fluorouracil derivative UFT on thymidylate synthetase and thymidine kinase in rat colorectal tumors.
Sakamoto S; Kawachi Y; Iwama T; Kuwa K; Suzuki T; Mitamura T; Kudo H; Sassa S; Yoshimura S; Maemura T; Nakayama T; Ohsawa M; Hara Y
Anticancer Res; 1999; 19(1A):245-50. PubMed ID: 10226549
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of thymidine kinase activity in bladder carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Kamoi K; Miki T
Cancer; 2002 Nov; 95(10):2120-5. PubMed ID: 12412165
[TBL] [Abstract][Full Text] [Related]
26. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
27. Activities of some enzymes of pyrimidine and DNA synthesis in a rat transplantable hepatoma and human primary hepatomas, in cell lines derived from these tissues, and in human fetal liver.
Cummins RR; Balinsky D
Cancer Res; 1980 Apr; 40(4):1235-9. PubMed ID: 6244089
[TBL] [Abstract][Full Text] [Related]
28. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
[TBL] [Abstract][Full Text] [Related]
29. Metabolic effects of novel N-1-sulfonylpyrimidine derivatives on human colon carcinoma cells.
Glavas-Obrovac L; Karner I; Stefanić M; Kasnar-Samprec J; Zinić B
Farmaco; 2005; 60(6-7):479-83. PubMed ID: 15913614
[TBL] [Abstract][Full Text] [Related]
30. Thymidylate synthetase and thymidine kinase activities in rat growing cartilage.
Amano M
Bull Tokyo Med Dent Univ; 1987 Mar; 34(1):1-8. PubMed ID: 3471366
[TBL] [Abstract][Full Text] [Related]
31. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
32. [Cathepsin D activity in human ovarian carcinoma].
Reich W; Wagner F; Hofmann KD; Marzotko F; Schmeisser G
Zentralbl Gynakol; 1984; 106(3):196-200. PubMed ID: 6702349
[TBL] [Abstract][Full Text] [Related]
33. Targeted and non-targeted actions of anti-cancer drugs.
Weber G; Prajda N
Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
[TBL] [Abstract][Full Text] [Related]
34. Behavior of activities of thymidine metabolizing enzymes in human leukemia-lymphoma cells.
Shiotani T; Hashimoto Y; Tanaka T; Irino S
Cancer Res; 1989 Mar; 49(5):1090-4. PubMed ID: 2917346
[TBL] [Abstract][Full Text] [Related]
35. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
Weber G; Nagai M; Prajda N; Nakamura H; Szekeres T; Olah E
Cancer Commun; 1991 Apr; 3(4):127-32. PubMed ID: 2025497
[TBL] [Abstract][Full Text] [Related]
36. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
[TBL] [Abstract][Full Text] [Related]
37. Relative activities of thymidylate synthetase and thymidine kinase in 1,2-dimethylhydrazine-induced colon carcinomas in rats.
Sakamoto S; Kuwa K; Tsukada K; Sagara T; Kasahara N; Okamoto R
Carcinogenesis; 1987 Mar; 8(3):405-8. PubMed ID: 3815735
[TBL] [Abstract][Full Text] [Related]
38. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
39. Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514.
Schultz RM; Patel VF; Worzalla JF; Shih C
Anticancer Res; 1999; 19(1A):437-43. PubMed ID: 10226579
[TBL] [Abstract][Full Text] [Related]
40. [Dihydropyrimidine dehydrogenase and thymidylate synthase in colon carcinoma].
Hamaji M; Nishida T; Miyazaki S; Nishida Y
Gan To Kagaku Ryoho; 2002 Jun; 29(6):889-93. PubMed ID: 12090040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
